• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

US senators push drugmakers for details on low-cost insulin programs

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 31, 2023 at 10:22: AM
via Two U.S. senators are demanding that the nation's three largest insulin makers, Novo Nordisk , Eli Lilly, and Sanofi, provide details by Sept. 15 of their programs to help Americans get their insulin for $35 a month or less.

article source
 




Top Bottom
Back
Quote